Table 1.
The relationship between CDK9 expression and clinicopathological features of osteosarcoma patients.
| Clinicopathological features | Number of cases |
CDK9 Expression low |
CDK9 expression high |
P value |
|---|---|---|---|---|
| (n, %) | (n, %) | (n, %) | ||
| All patients | 70(100) | 23 (32.9) | 47(67.1) | |
| Age, year | ||||
| ≤18 | 20(28.6) | 5 (25.0) | 15(75.0) | 0.1719 |
| >18 | 50(71.4) | 18 (36.0) | 32(64.0) | |
| Gender | ||||
| Male | 46(65.7) | 15(32.6) | 31(67.4) | 0.6799 |
| Female | 24(34.3) | 8(33.3) | 16(66.7) | |
| Tumor site | ||||
| Femur | 33(47.1) | 10(30.3) | 23(69.7) | 0.9945 |
| Tibia | 13(18.6) | 4(30.8) | 9(69.2) | |
| Humeral bone | 8 (11.4) | 3(37.5) | 5(62.5) | |
| Other | 16(22.9) | 6(37.5) | 10(62.5) | |
| Metastasis | ||||
| Absent | 13(18.6) | 8(61.5) | 5(38.5) | 0.0064a |
| Present | 57(81.4) | 14(24.6) | 43(75.4) | |
| Recurrence | ||||
| Absent | 47(67.1) | 16(34.0) | 31(66.0) | 0.9899 |
| Present | 23(32.9) | 7(30.4) | 16(69.6) |
a
Statistically significant.